テレフタール酸の代謝(第2報) : 血漿内テレフタール酸の消長および生物学的半減期
スポンサーリンク
概要
- 論文の詳細を見る
Changes of terephthalic acid concentration in blood plasma were studied in the rabbit, and the half-life of terephthalic acid in plasma was determined in the rabbit and the rat. Terephthalic acid, when intraperitoneally injected, was rapidly absorbed in plasma and then excreted from plasma into the urine through the kidney. Terephthalic acid concentration in plasma reached a maximum level within 1 hour after the injection and decreased gradually, and any detectable amount was not found after 24 hours. Half-life of terephthalic acid in plasma is about 1.8 hours. (Fig. 1). Terephthalic acid suspension was orally administered in doses of 200 and 100 mg./kg. each. Terephthalic acid concentration in plasma reached a maximum level within 8 to 10 hours, and decreased slowly. In this case terephthalic acid concentration in plasma was very low, which was only 11.7 μg./ml. at the 8th hour after the administration of 200 mg./kg. Half-life of terephthalic acid in plasma after its oral administration is 27 hours. (Fig. 1). These results indicate that tereththalic acid concentration in plasma after its oral administration is more influenced by its absorption through the digestive tract than by its excretion thruogh the kidney. Urine excretion ratios in the rabbit were 67% by oral administration and 93% by intraperitoneal injection. In the rat, half-life of terephthalic acid in plasma is about 1.0 hour in the case of intraperitoneal injeation and about 3.4 hours. after oral administration. Both the rates of urinary excretion and absorption through the gastrointestinal tract of terephthalic acid in the rat are faster than those in the rabbit.
- 社団法人日本薬学会の論文
- 1966-10-25
著者
-
星 昭夫
国立がんセンター病院研究所薬効試験部
-
星 昭夫
国立がんセンター研・薬効試験部
-
榑谷 和男
国立がんセンター研究所
-
星昭 夫
国立がんセンター研究所薬効試験部
-
矢内 玲子
Pharmacology Division National Cancer Center Research Institute
-
高木 潤子
国立がんセンター研究所
-
榑谷 和男
Pharmacology Division National Cancer Center Research Institute
-
槫谷 和男
Pharmacology Division National Cancer Center Research Institute
-
矢内 玲子
国立がんセンター研究所
関連論文
- Pharmacokineticsにもとづいたmother compoundとそのanalogueの抗腫瘍活性の比較の試み : 非小細胞肺癌と小細胞肺癌に対するプラチナ化合物の検討
- Studies on the Chemical Synthesis of Potential Antimetabolites. XXIV. The Synthesis and Antitumor Activities of p-Tosylhydrazones of 2-Formylpyridine 1-Oxides and 2-Formylazoles 3-Oxides
- Metabolites of 5-^3H-Cyclocytidine in Monkeys Given Single Intravenous Injection
- 環状ヒドラジド構造を含む複素環化合物の合成とその抗腫瘍性について
- Metabolism of Cyclocytidine and Aracytidine in Mice
- HTCAからみた肺癌の原発巣と転移巣の薬剤感受性の違い
- 82 切除肺癌のColoney assayの成績
- ロ-32 切除肺癌のColony assayとその結果に基いた術後化学療法の試み
- Effect of centrophenoxine on cyclophosphamide contration in blood
- Inhibition by Cyclocytidine of Nucleic Acid Biosynthesis in Cultured Cells (L5178Y)
- Specific Inhibition of DNA Synthesis by Cyclocytidine
- Inhibition of Guanine Deaminase with Derivatives of Imidazole
- Inhibition of Guanine Deaminase with Derivatives of 5-Amino-4-imidazolecarboxamide
- Enhancement of Antitumor Activity of Cyclophosphamide with Imipramine
- ヒト肺小細胞癌培養細胞株のin vitro抗癌剤感受性試験
- 112 Recombinant Human Tumor Necrosis Factor(rHu-TNF)のヒト肺癌培養細胞株に対する抗腫瘍効果の検討 : HTCAを用いて
- ロ-31 原発性肺癌におけるHuman Tumor Colony-forming Assay(Human Tumor Stem Cell Assay)と臨床効果との相関性について
- 83 肺癌に対するHTCAを用いたBioassayによるCisplatin血中濃度の測定と臨床効果 : 投与方法による検討
- 肺癌におけるHuman Tumor Clonogenic Cell Assay(HTCA)と臨床効果との相関
- 3.Human tumor in vitro colony assayにもとづき化学療法を行った胸水型肺腺癌の1例(第76回日本肺癌学会関東支部会)
- cDDPによるNK活性の変動(steroid hormone併用の問題点) : 関東支部 : 第78回日本肺癌学会関東支部会
- 387 原発性肺癌に対するhuman recombinant IL-2投与時の血中NK活性の変動について
- 108 ヒト肺癌培養細胞株に対するCisplatinとCarboplatinの抗腫瘍活性の検討
- テレフタール酸の代謝(第2報) : 血漿内テレフタール酸の消長および生物学的半減期
- Studies on the Chemical Constituents of Rutaceous Plants. LX. Development of a Versatile Method for Syntheses of the Antitumor Benzo [c] phenanthridine Alkaloids. (9). Efficient Syntheses and Antitumor Activities of Nitidine and Related Nonphenolic Benzo
- Antitumor Activity of Shikonin, Alkannin and Their Derivatives. II. X-Ray Analysis of Cyclo-alkannin Leucoacetate, Tautomerism of Alkannin and Cyclo-alkannin and Antitumor Activity of Alkannin Derivatives
- Mode of Action of 5-Fluorouridine 5'-Phosphate in Vivo and in Vitro
- Antitumor Activity of 1-Alkylcarbamoyl Derivatives of 5-Fluorouracil against L1210 Leukemia
- Distribution of Cyclocytidine in Tissues
- Autoradiographic Study on the Distribution of Cyclocytidine in Mice
- Resistance of Cyclocytidine to Cytidine Deaminase
- Studies on Antitumor Agents. III. Metabolites of 5 (4)-Amino-4 (5)-imidazolethiocarboxamide Derivatives in Urine
- Antitumor Activity of Psychotropic Drugs and Their Synergic Action with Cyclophosphamide
- Studies on Antitumor Agents. I. Antitumor Activity of 5 (4)-Amino-4 (5)-imidazolecarboxamide Analogs
- Toxicity of Terephthalic Acid
- 肺癌の継代培養細胞及び初代培養細胞に対するMTT colorimetric assay を用いた新しい抗癌剤感受性試験の試み
- MINI-hybrid assayによるヒト肺癌培養細胞に対する抗癌剤感受性テスト
- 抗腫瘍薬とヒト腫瘍細胞の薬剤感受性
- 107 HTCAを用いた肺癌培養細胞株に対するシスプラチン、ビンデシン、エトポシドの併用効果の検討 : simultaneous or sequentail use
- 肺癌におけるColony assayの意義(臨床)
- 肺がんにおけるColony Assayの成績(基礎)
- 肺癌におけるcolony assayの成績(基礎)
- Effect of Terephthalic Acid on the Activities of p-Dimethylaminoazobenzene Metabolizing Enzymes in Rat Liver
- Distribution of Terephthalic Acid in Tissues
- Effect of Terephthalic Acid on the Bound Dye Level in the Liver of Rat fed p-Dimethylaminoazobenzene.
- Metabolism of Terephthalic Acid. III. Absorption of Terephthalic Acid from Gastrointestinal Tract and Detection of Its Metabolites.
- Effect of Terephthalic Acid upon Sulfadimethoxine Contents in Blood Plasma.
- ラット胎盤性ラグトージェンの抽出と精製
- テレフタール酸のマウスの発育,繁殖に及ぼす影響
- 組織内テレフタール酸含量
- テレフタール酸の血漿内サイアミン濃度に及ぼす影響 : 1. 血漿内サイアミン濃度増加及び持続性
- テレフタール酸の血漿内チアミン濃度におよぼす影響 : II. 飼料へのテレフタール酸添加量と血漿内チアミン濃度の関係
- マウス泌乳能力の指標としての諸形質間の相関について
- 乳腺の発育と機能に対するprolactinの関与
- マウス下垂体のプロラクチン分泌と乳腺発育におよぼすヘキセストロールジ脂肪酸エステルの影響
- プロラクチンに対するマウス乳腺の感受性におよぼす乳癌ウィルスの影響
- マウス乳腺発育におけるProlactinおよびGrowth hormoneの重要性